文献速递自身炎症与 IgG4 相关病

A20单倍剂量不足(HA20):一种新识别的NF-kB介导自身炎症性疾病的临床表型与疾病病程

A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease.
PubMed 文献 · Ann Rheum Dis · 2018-01-09

本研究通过标准化数据收集表汇总了来自7个家系的16例(女性13例)A20单倍剂量不足(HA20)患者,描述其临床表型与疾病病程。HA20常于儿童早期起病,以复发性口腔、生殖器和/或胃肠道溃疡为主要表现,临床表现高度异质,即使在同一家系内也差异显著;细胞因子抑制剂可有效抑制7/9例患者的全身炎症。

要点

  • 复发性口腔、生殖器和/或胃肠道溃疡是HA20的标志性特征(16/16例)。
  • HA20临床表现高度异质,即使在同家系内也差异显著。
  • 细胞因子抑制剂有效抑制7/9例患者的全身炎症。

核心结论

  • 早发性复发性口腔、生殖器和/或胃肠道溃疡是HA20的标志性特征。
  • 其他临床表现的频率和强度高度多变。
  • 治疗方案应基于疾病严重程度,常需细胞因子抑制剂控制复发。

研究设计与样本

  • 本研究为病例系列,采用标准化数据收集表收集初始发表的全部病例及此后通过合作识别的额外病例。
  • 共纳入来自7个家系的16例(女性13例)基因诊断确诊为HA20的患者。

主要发现

  • 疾病通常于儿童早期起病,起病年龄范围为出生后第一周至29岁。
  • 主要临床症状包括复发性口腔、生殖器和/或胃肠道溃疡(16/16)、肌肉骨骼症状(9/16)、胃肠道症状(9/16)、皮肤病变(8/16)、发作性发热(7/16)和反复感染(7/16)。
  • 临床表现高度多变,即使在同一家系内也差异显著;复发缓解型病程最常见,1例患者死亡。
  • 实验室异常包括急性期反应物升高及多种自身抗体波动性出现,如抗核抗体(检测10例中4例阳性)和抗dsDNA抗体(检测5例中2例阳性)。
  • 不同部位组织活检显示非特异性慢性炎症(检测12例中6例)、1例患者表现符合V型狼疮性肾炎,2例患者见脓疱、2例患者结果正常。

临床怎么用

  • 所有患者均接受治疗:4/16例使用秋水仙碱,12/16例使用各种免疫抑制剂。
  • 细胞因子抑制剂有效抑制7/9例患者的全身炎症。
  • 作者认为治疗方案应基于疾病严重程度,常需细胞因子抑制剂控制复发。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The association between mutations in TNFAIP3, encoding the NF-kB regulatory protein A20, and a new autoinflammatory disease has recently been recognised. This study aims at describing the clinical phenotypes and disease course of patients with A20 haploinsufficiency (HA20). METHODS: Data for all cases from the initial publication, and additional cases identified through collaborations since, were collected using standardised data collection forms. RESULTS: A total of 16 patients (13 female) from seven families with a genetic diagnosis of HA20 were included. The disease commonly manifested in early childhood (range: first week of life to 29 years of age). The main clinical symptoms were recurrent oral, genital and/or gastrointestinal ulcers (16/16), musculoskeletal (9/16) and gastrointestinal complaints (9/16), cutaneous lesions (8/16), episodic fever (7/16), and recurrent infections (7/16). Clinical phenotypes varied considerably, even within families. Relapsing-remitting disease course was most common, and one patient died. Laboratory abnormalities included elevated acute-phase reactants and fluctuating presence of various autoantibodies such as antinuclear antibodies (4/10 patients tested) and anti-dsDNA (2/5). Tissue biopsy of different sites revealed non-specific chronic inflammation (6/12 patients tested), findings consistent with class V lupus nephritis in one patient, and pustules and normal results in two patients each. All patients were treated: 4/16 received colchicine and 12/16 various immunosuppressive agents. Cytokine inhibitors effectively suppressed systemic inflammation in 7/9 patients. CONCLUSIONS: Early-onset recurrent oral, genital and/or gastrointestinal ulcers are the hallmark feature of HA20. Frequency and intensity of other clinical manifestations varied highly. Treatment regimens should be based on disease severity, and cytokine inhibitors are often required to control relapses.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Aeschlimann FA, Batu ED, Canna SW, et al. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease. Ann Rheum Dis. 2018. PMID: 29317407. doi:10.1136/annrheumdis-2017-212403

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。